RE:RE:RE:RE:RE:4050???Staghorn,
Discussion on 4050 handled not by Pierre, but by the Chief Medical Officer. He was openly enthusiastic about the prospects, with the final patients finishing phase 1 trials by the end of June, phase 1/2b will be initiated in the second half of 2014. If results on phase 1/2b support the indications from the animal trials, PLI will need security protection from those beating a path to PLI's doors (his words). He termed 4050 the diamond in PLI's portfolio. In terms of what has been discussed, to this point of the webcast, 4050 has been a major part of it.
I was surprised by the fact that only now, the last of the patients have entered the phase 1 clinical trial. I and I suppose yourself, would have thought this would have concluded some time earlier. But like a previous postered mentioned, Pierre said not hearing anything with regards to phase 1 trials on 4050 is actually a good thing.
Good luck,
Felco